GTCR LLC’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.6M | Hold |
20,150,005
| – | – | 5.18% | 3 |
|
|
2025
Q1 | $44.5M | Hold |
20,150,005
| – | – | 4.99% | 3 |
|
|
2024
Q4 | $110M | Hold |
20,150,005
| – | – | 10.56% | 3 |
|
|
2024
Q3 | $167M | Hold |
20,150,005
| – | – | 13.05% | 3 |
|
|
2024
Q2 | $144M | Sell |
20,150,005
-1,531,028
| -7% | -$11M | 12.02% | 3 |
|
|
2024
Q1 | $188M | Hold |
21,681,033
| – | – | 15.96% | 3 |
|
|
2023
Q4 | $142M | Hold |
21,681,033
| – | – | 8.62% | 3 |
|
|
2023
Q3 | $217M | Hold |
21,681,033
| – | – | 13.15% | 3 |
|
|
2023
Q2 | $269M | Hold |
21,681,033
| – | – | 12.63% | 3 |
|
|
2023
Q1 | $304M | Hold |
21,681,033
| – | – | 15.02% | 3 |
|
|
2022
Q4 | $310M | Hold |
21,681,033
| – | – | 18.04% | 4 |
|
|
2022
Q3 | $554M | Hold |
21,681,033
| – | – | 32.68% | 1 |
|
|
2022
Q2 | $616M | Hold |
21,681,033
| – | – | 21.97% | 2 |
|
|
2022
Q1 | $765M | Hold |
21,681,033
| – | – | 24.22% | 2 |
|
|
2021
Q4 | $908M | Hold |
21,681,033
| – | – | 27.7% | 2 |
|
|
2021
Q3 | $1.06B | Sell |
21,681,033
-2,931,441
| -12% | -$144M | 26.99% | 2 |
|
|
2021
Q2 | $1.03B | Sell |
24,612,474
-3,034,041
| -11% | -$127M | 28.61% | 2 |
|
|
2021
Q1 | $985M | Hold |
27,646,515
| – | – | 27.81% | 2 |
|
|
2020
Q4 | $775M | Buy |
+27,646,515
| New | +$775M | 19.37% | 2 |
|